A new mechanism for decreasing aggregation of recombinant human interferon-gamma by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20.

scientific article published on February 2002

A new mechanism for decreasing aggregation of recombinant human interferon-gamma by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JPS.10033
P698PubMed publication ID11835212

P50authorTheodore W RandolphQ87452433
P2093author name stringJeffrey L Cleland
John F Carpenter
Serena D Webb
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)543-558
P577publication date2002-02-01
P1433published inJournal of Pharmaceutical SciencesQ3186933
P1476titleA new mechanism for decreasing aggregation of recombinant human interferon-gamma by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20.
P478volume91

Reverse relations

cites work (P2860)
Q40244595Characterization of the physical stability of a lyophilized IgG1 mAb after accelerated shipping-like stress
Q48170015Dual Effect of Histidine on Polysorbate 20 Stability: Mechanistic Studies
Q47902036Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy
Q57105311Effect of cryoprotectants on the stability and aerosol performance of nebulized aviscumine, a 57-kDa protein
Q90547946Investigation of the reversibility of freeze/thaw stress-induced protein instability using heat cycling as a function of different cryoprotectants
Q41865980New methods allowing the detection of protein aggregates: a case study on trastuzumab
Q35563682Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation
Q64883180PolyBall: A new adsorbent for the efficient removal of endotoxin from biopharmaceuticals.
Q36085672Protein drug stability: a formulation challenge
Q44090649Protein powders for encapsulation: a comparison of spray-freeze drying and spray drying of darbepoetin alfa
Q37579215Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
Q51295365Reduced Subvisible Particle Formation in Lyophilized Intravenous Immunoglobulin Formulations Containing Polysorbate 20.
Q33649828Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies.
Q42917708Synthesis, characterization and assessment of suitability of trehalose fatty acid esters as alternatives for polysorbates in protein formulation
Q46402320Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers.

Search more.